Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Apply
UB-VV111 with Rapamycin
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step